FDA inspection
Sanofi Chimie, Division of Sanofi: FDA inspection ending Apr 27, 2018
FDA inspection 1053482 · Voluntary Action Indicated (VAI) · Vitry Sur Seine
Key facts
| Inspection ID | 1053482 |
|---|---|
| Firm | Sanofi Chimie, Division of Sanofi |
| FEI number | 3002808000 |
| Address | Centre de Production de Vitry, 9 quai Jules Guesde |
| City | Vitry Sur Seine |
| Fiscal year | 2018 |
| Inspection end date | Apr 27, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data